Understanding Peptide Purity: HPLC and Mass Spectrometry Testing
Peptide purity is verified through reverse-phase HPLC (which measures purity by UV absorbance) and mass spectrometry (which confirms molecular identity). This article explains both techniques and what the results mean for research quality.
Research reference only. The information in this article is a summary of peer-reviewed scientific literature. It does not constitute medical advice and is not intended to guide human use. See our full disclaimer.
Understanding Peptide Purity: HPLC, Mass Spectrometry, and How to Read a Certificate of Analysis
When evaluating research-grade peptides, purity is the foundational quality metric. Two analytical techniques — high-performance liquid chromatography (HPLC) and mass spectrometry (MS) — provide complementary data that together constitute the industry standard for characterizing synthetic peptide quality. Understanding what each test measures and how to interpret the Certificate of Analysis (CoA) that reports their results is an essential competency for peptide researchers.
What HPLC Measures: Purity by Area Percentage
High-performance liquid chromatography separates mixture components based on differential interactions with a stationary phase (typically a C18 reversed-phase column) and a mobile phase gradient (water with an organic modifier such as acetonitrile, with acid modifiers like trifluoroacetic acid). As peptide components elute from the column at characteristic retention times, they are detected by a UV absorbance detector.
Detection wavelength: The standard detection wavelength for peptides is 220 nm, which corresponds to absorbance by the peptide bond itself. This is preferred over 280 nm (which detects aromatic residues tyrosine and tryptophan) because it provides a signal proportional to all residues regardless of sequence, giving a more universal measure of mass distribution across all eluting components.
Purity calculation: The HPLC chromatogram shows absorbance as a function of time. Each peak represents a distinct molecular species. Purity is reported as the percentage of total peak area attributable to the main product peak:
Purity (%) = (Main peak area / Total peak area) × 100
This is an area-normalized calculation and does not require an external reference standard, which is why it is practical for novel synthetic compounds. However, it does not distinguish between compounds with very different extinction coefficients — a limitation acknowledged in the analytical chemistry literature (Snyder, Kirkland & Dolan, Introduction to Modern Liquid Chromatography).
What >98% Purity Means — and What It Doesn't
A purity of >98% by HPLC indicates that the main product peak constitutes at least 98% of the total UV-absorbing area in the chromatogram. This is the benchmark commonly cited as "research grade" in the peptide industry.
A purity of <95% indicates a meaningful fraction of impurities that could confound biological assay results, receptor binding studies, or pharmacokinetic characterizations. The impact depends on whether the impurities are biologically inert or active at the assay concentrations used.
Importantly, HPLC purity alone cannot confirm molecular identity. A 99% pure sample could theoretically be the wrong compound at high purity — a scenario prevented only by mass spectrometry confirmation (below).
Common Impurities in Synthetic Peptides
The types of impurities most frequently encountered in HPLC analysis of synthetic peptides are well-documented in the peptide synthesis literature (Coin, Beyermann & Bienert, 2007; Nature Protocols):
Deletion sequences: The most common impurity class. During solid-phase peptide synthesis (SPPS), incomplete coupling of a residue at any step results in a "deletion" — a sequence missing one or more amino acids from the full-length product. These sequences are typically shorter than the target peptide and elute at different retention times on HPLC. High-purity SPPS protocols minimize deletions through capping steps after each coupling.
Oxidized methionine: Methionine (Met) contains a thioether side chain that is readily oxidized to the sulfoxide form during synthesis, purification, or storage in the presence of oxygen or peroxide contaminants. Met-sulfoxide elutes at a slightly different retention time and appears as a distinct shoulder or peak adjacent to the main product. Oxidized Met impurities are identifiable by a characteristic +16 Da mass shift in the MS spectrum.
Incomplete deprotection products: SPPS uses temporary protecting groups on side chains (Fmoc chemistry). Incomplete removal during cleavage can leave residual protecting groups on the final product, detectable by mass spectrometry as mass adducts.
Racemized residues: Under certain synthesis conditions, epimerization at alpha-carbons can produce D-amino acid-containing sequences that are difficult to separate by HPLC but may have different biological activity.
Mass Spectrometry: Confirming Molecular Identity
While HPLC quantifies purity, mass spectrometry (MS) confirms identity by measuring the mass-to-charge ratio (m/z) of ionized peptide species.
The standard technique for peptides is electrospray ionization mass spectrometry (ESI-MS), which gently ionizes peptides in solution by applying a high electric field. The ionization process produces multiply charged species — a peptide of molecular weight M acquiring z protons appears at:
m/z = (M + z × 1.008) / z
The expected m/z is calculated from the peptide's theoretical molecular weight (derived from the sum of residue masses plus water). The observed m/z from the instrument is compared to this expected value. A match within the instrument's mass accuracy specification (typically ±0.1–1.0 Da for unit-resolution instruments, sub-ppm for high-resolution instruments) confirms that the main product has the correct molecular formula.
What MS does not confirm: Mass spectrometry confirms molecular weight, but it cannot distinguish between sequence isomers (peptides with the same composition in different orders) or stereoisomers (D- vs. L-amino acid variants of the same sequence). For sequence confirmation, tandem MS (MS/MS fragmentation) would be required.
How to Read a Certificate of Analysis (CoA)
A Certificate of Analysis is the primary quality document provided with a research peptide. A complete, well-structured CoA should contain the following elements:
1. Compound Identity
- Full systematic name and/or recognized shorthand name
- Sequence in single-letter or three-letter amino acid code
- Molecular formula and theoretical molecular weight (MW)
- CAS number or internal catalog number
2. Lot Number and Batch Date
Essential for reproducibility documentation. Research protocols should record lot numbers to allow inter-experiment comparison.
3. HPLC Purity Data
- Purity percentage (area %)
- Column type and mobile phase conditions (allows assessment of method suitability)
- Retention time of main peak
- Chromatogram image or data table
4. Mass Spectrometry Data
- Observed m/z value(s) with charge states
- Expected m/z value(s) calculated from theoretical MW
- Match confirmation (pass/fail or delta)
- Instrument type (may be noted)
5. Additional Tests (Where Applicable)
- Water content (Karl Fischer titration) — important for accurate concentration calculation
- Residual solvent content
- Appearance (color, physical form)
- Endotoxin testing (EU/mg by LAL assay) — increasingly provided for higher-grade research peptides
6. Storage Recommendations
Temperature, light, humidity, and recommended solvent from the manufacturer's stability data.
Why Both Tests Together Are the Standard
Neither test alone provides sufficient quality assurance for research use:
| Test | Confirms | Does Not Confirm |
|---|---|---|
| HPLC (>98% purity) | Proportion of main product by UV area | Molecular identity |
| Mass spectrometry | Molecular weight (identity by mass) | Purity, absence of isobaric impurities |
Together, they establish: (1) that the product has the correct molecular weight; and (2) that it represents the dominant species in the sample. This dual standard is cited in published peptide research guidelines (Rosengren et al., 2013; Biopolymers: Peptide Science) and is the minimum that should be documented in any research protocol referencing a specific peptide compound.
For compound-specific quality benchmarks and purity data, refer to the individual entries in the peptide library.
References
- Coin, I., Beyermann, M., & Bienert, M. (2007). Solid-phase peptide synthesis: from standard procedures to the synthesis of difficult sequences. Nature Protocols, 2(12), 3247–3256.
- Snyder, L.R., Kirkland, J.J., & Dolan, J.W. (2010). Introduction to Modern Liquid Chromatography, 3rd ed. Wiley.
- Rosengren, K.J., et al. (2013). Quality control of synthetic peptides. Biopolymers: Peptide Science, 100(5), 453–463.